Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus
- PMID: 3281898
- PMCID: PMC259757
- DOI: 10.1128/iai.56.5.1030-1035.1988
Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus
Abstract
The relative colonizing abilities of Escherichia coli F-18, isolated from the feces of a healthy human, and E. coli F-18col-, a strain derived from it which does not make the E. coli F-18 colicin, were studied. In a previous report, it was shown that when each strain was fed individually to streptomycin-treated mice, at approximately 10(10) CFU per mouse, each colonized the large intestine at between 10(7) and 10(8) CFU/g of feces indefinitely. However, when simultaneously fed to mice, although E. coli F-18 colonized at about 10(8) CFU/g of feces, E. coli F-18col- dropped to a level of 10(3) CFU/g of feces within 3 to 5 days. In the present investigation, we show that when given enough time to establish a state of colonization, E. coli F-18col- persists in feces in high numbers despite subsequent challenge by E. coli F-18. Therefore, a major defect in the ability of E. coli F-18col- to colonize in the presence of E. coli F-18 appears to be in initiating that state. In addition, when mucus was scraped from the cecal wall and, without further treatment, was inoculated with E. coli F-18 or F-18col-, both strains grew well. However, when cecal mucus was inoculated with both strains simultaneously, E. coli F-18 grew far more rapidly than E. coli F-18col-. Moreover, neither strain grew in cecal luminal contents. Together, these data suggest the possibility that both E. coli F-18 and F-18col- must grow in mucus to colonize the streptomycin-treated mouse large intestine, that E. coli F-18col- is eliminated by E. coli F-18 because it does not grow in mucus as well as E. coli F-18, and that E. coli F-18col- can resist elimination by E. coli F-18 if it is allowed enough time to establish itself within the mucus layer.
Similar articles
-
Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12.Infect Immun. 1989 Oct;57(10):3022-9. doi: 10.1128/iai.57.10.3022-3029.1989. Infect Immun. 1989. PMID: 2570752 Free PMC article.
-
Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of adhesion to mucosal receptors.Infect Immun. 1988 May;56(5):1036-43. doi: 10.1128/iai.56.5.1036-1043.1988. Infect Immun. 1988. PMID: 2833441 Free PMC article.
-
Escherichia coli F-18 phase locked 'on' for expression of type 1 fimbriae is a poor colonizer of the streptomycin-treated mouse large intestine.Microb Pathog. 1993 Jan;14(1):33-43. doi: 10.1006/mpat.1993.1004. Microb Pathog. 1993. PMID: 8100608
-
In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharide-deficient mutant.Infect Immun. 1987 Dec;55(12):2884-90. doi: 10.1128/iai.55.12.2884-2890.1987. Infect Immun. 1987. PMID: 3316026 Free PMC article.
-
An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine.Infect Immun. 2003 Apr;71(4):2142-52. doi: 10.1128/IAI.71.4.2142-2152.2003. Infect Immun. 2003. PMID: 12654836 Free PMC article.
Cited by
-
Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration.mBio. 2013 Jul 2;4(4):e00430-13. doi: 10.1128/mBio.00430-13. mBio. 2013. PMID: 23820397 Free PMC article.
-
Impact of enteric bacterial infections at and beyond the epithelial barrier.Nat Rev Microbiol. 2023 Apr;21(4):260-274. doi: 10.1038/s41579-022-00794-x. Epub 2022 Sep 29. Nat Rev Microbiol. 2023. PMID: 36175770 Review.
-
Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12.Infect Immun. 1989 Oct;57(10):3022-9. doi: 10.1128/iai.57.10.3022-3029.1989. Infect Immun. 1989. PMID: 2570752 Free PMC article.
-
The impact of therapeutic-dose induced intestinal enrofloxacin concentrations in healthy pigs on fecal Escherichia coli populations.BMC Vet Res. 2020 Oct 8;16(1):382. doi: 10.1186/s12917-020-02608-9. BMC Vet Res. 2020. PMID: 33032597 Free PMC article.
-
The importance of P and type 1 fimbriae for the persistence of Escherichia coli in the human gut.Epidemiol Infect. 1992 Jun;108(3):415-21. doi: 10.1017/s095026880004992x. Epidemiol Infect. 1992. PMID: 1350997 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources